Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 248,168 | 227,188 | 193,118 | 165,083 | 146,017 |
| Cost of Goods | 23,364 | 24,488 | 20,508 | 17,848 | 24,712 |
| Gross Profit | 224,804 | 202,700 | 172,610 | 147,235 | 121,305 |
| Operating Expenses | 197,929 | 180,378 | 151,380 | 164,986 | 140,588 |
| Operating Income | 27,239 | 22,810 | 21,738 | -16,903 | -18,571 |
| Other Income | 4,416 | 6,218 | 3,608 | 1,472 | 665 |
| Pre-tax Income | 31,655 | 29,028 | 25,346 | -15,431 | -17,906 |
| Income Tax | 8,318 | -86,525 | 138 | 136 | 104 |
| Net Income Continuous | 23,337 | 115,553 | 25,208 | -15,567 | -18,010 |
| Net Income | $23,337 | $115,553 | $25,208 | $-15,567 | $-18,010 |
| EPS Basic Total Ops | 0.43 | 2.17 | 0.50 | -0.35 | -0.41 |
| EPS Basic Continuous Ops | 0.43 | 2.17 | 0.50 | -0.35 | -0.41 |
| EPS Diluted Total Ops | 0.42 | 2.11 | 0.48 | -0.35 | -0.41 |
| EPS Diluted Continuous Ops | 0.42 | 2.11 | 0.48 | -0.35 | -0.41 |
| EPS Diluted Before Non-Recurring Items | 0.42 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $30,282 | $22,603 | $22,473 | $-14,345 | $-6,703 |